About Dr. Vivian W. Bucay

Bucay Center for Dermatology and Aesthetics Advice Media

Dr. Vivian W. Bucay

EDUCATION
Undergraduate
Johns Hopkins University (full scholarship)
Baltimore, MD
Aug 1979 – May 1983
Bachelor of Arts in Natural Sciences
Medical School
Baylor College of Medicine
Houston, TX
Aug 1983 – June 1987
Medical Doctorate
Internship
Baylor College of Medicine
Houston, TX
July 1987 – June 1988
Internship, Pediatrics
Residency
University of Miami School of Medicine
Miami, FL
July 1988 – June 1989
First-year Residency in Dermatology
Residency
Baylor College of Medicine
Houston, TX
July 1989 – June 1991
Residency in Dermatology
Honors
National Merit Scholar (1979)
Phi Beta Kappa
Teamster International Scholarship (1979-1983)
Baylor Trustee Scholarship (1985)
MEETING PRESENTATIONS
  1. Television “Un Nuevo Dia” — Discussed Facial Rejuvenation using laser resurfacing. June 1998, Mexico City, Mexico.
  2. Dermatology Nurses Association monthly meeting. Discussed Tazarotene in the treatment of acne vulgaris. Houston, Texas. August 2000.
  3. Headed Round Table Discussion of Tazarotene in the treatment of acne vulgaris and anti- aging. New Orleans, Louisiana. September 2000.
  4. Society for Cosmetic Physicians of Western Australia — Guest Speaker: The Art of Facial Rejuvenation. Perth, Western Australia March 2002
  5. Co-Chair for Asia Pacific Expert Injectors Conference — Guest Speaker: Advanced Applications of Botox. Gave course and led workshop at the conference. Bali, Indonesia March 2002
  6. Advances in Facial Contouring, Vancouver, Canada. August 2003
  7. Annual meeting of the Society for Dermatology Physician Assistants — Guest Speaker: The Art of Facial Rejuvenation. San Antonio, Texas November 15, 2003
  8. American Society for Cosmetic Dermatology and Aesthetic Surgery: “The Use of Fillers in Facial Rejuvenation.” Las Vegas, Nevada December 2003
  9. 20th Annual Update Dermatology and All that Jazz 2004 Conference, sponsored by Tulane University, “The use of Fillers for Facial Aesthetic Enhancement. New Orleans, Louisiana April 2004
  10. American Society of Aesthetic and Plastic Surgery: “The Evolving Use of Botulinum Toxin and Fillers in Facial Rejuvenation.” Chicago, Illinois, September 2005
  11. Skin Disease Education Foundation Meeting – Women’s and Pediatric Dermatology: “The Evolving Use of Botulinum Toxin and Fillers in Facial Rejuvenation.” San Antonio, Texas, September 2006.
  12. Keynote Speaker at the KLRN Women’s Health Conference, Laredo, Texas. January 2007.
  13. Co-chair for CME-approved course, “Shaping the Course of Aesthetic Medicine: Advanced Techniques.” San Antonio, Texas, February 2007.
  14. Keynote Speaker at the Annual Women in Medicine Dinner of the Bexar County Medical Society, San Antonio, Texas, September 2007.
  15. Faculty, Facial Aesthetics National Exchange Forum Consultant Meeting, The Science of Rejuvenation, sponsored by Allergan, San Diego, California, 2008
  16. Texas Dermatological Association, annual spring meeting, “The Evolving Use of Botulinum Toxin and Fillers,” San Antonio, Texas, May 2008
  17. Co-chair for CME- approved course, “Injector Training Regional Symposium,” Austin, Texas, Aug. 9, 2008
  18. Speaker for CME series “Differentiating Among Hyaluronic Acid Fillers,” Presentations given in San Jose, San Diego, Phoenix, Houston, Dallas, and New York City during September, October, and November, 2008
  19. Steering Committee and Faculty, Advances in Cosmetic Therapy (ACT) CME Initiative: Advances in Cosmetic Therapy: A Focus on BoNT-A. October 2008, patient injections and filming in preparation for Curriculum Content Development Meeting, Dallas, TX, December 2008. Faculty speaker for meetings in Miami, FL, Sept 2009, Jacksonville, FL, Oct 2009, and San Antonio, TX, Oct 2009. Santa Fe, NM, Jan 2010
  20. Faculty, PALETTE (Progressive Aesthetic Learning Essential to Technical Expertise) CME Initiative, 2009, 2010, 2011, 2012. Course leader of hands-on workshops held throughout the US
  21. Guest Speaker, Annual Meeting of the AVEENO/Neutrogena sales force, “Sun protection for health and Beauty,” Dallas, Texas, January 2009
  22. Guest Speaker, Annual Meeting of the Novartis Pharmaceuticals sales force, oncology division, “Surviving Stage 4 Melanoma: A Patient’s Perspective,” Orlando, FL, June 2009
  23. Guest Speaker, BODY Conference 2009, “Laser and Light Based Cellulite Treatment,” Royal College of Physicians, London, UK, November 2009
  24. Keynote Address, Annual Meeting of the Society of Dermatology Physician Assistants, “Surviving Advanced Melanoma,” Scottsdale, AZ, November 14, 2009
  25. Faculty, Cosmetic Surgery Forum 2009, Faculty Panels: Treatment Strategies for Hyperpigmentation; Cosmeceuticals in Clinical Practice; Fillers, Las Vegas, Nevada, Dec 4-6, 2009
  26. Invited Guest Speaker, Annual meeting of SEME (Sociedad Espanola de Medicina Estetica), “Topical Anesthetics for Medical and Cosmetic Procedures in Dermatology,” Barcelona, Spain, Feb. 2010
  27. Invited Speaker, Second Annual Dysport Meeting (Galderma, Brazil), “Combination Treatment with BoNT-A, Fillers, and Lasers,” Fort Lauderdale, FL, March 2010
  28. Faculty, Integrating New Neuromodulators CME Initiative, Hands-on instructional workshops, Austin, TX, April 2010, San Antonio, TX, June 2010
  29. Faculty Speaker, Combined Meeting of the ASDS and ASCDAS, “Medical Presentations, Photography, and Patient Confidentiality,” Chicago, IL, Oct. 2010
  30. Invited Guest Speaker, “Treatment Strategies for Melasma and Hyperpigmentation,” Elure (Syneron Topical Aesthetics) World Launch Media Event, Singapore, Nov. 2010
  31. Invited Guest Speaker, Annual Meeting of the Society of Dermatology Physician Assistants, “Combined Use of Fillers and Neuromodulators in Facial Aesthetics,” and “Fillers for Facial Contouring,” Grapevine, TX, Nov. 2010
  32. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Dec. 2010
  33. Medscape Education Dermatology CME Videos (3). “Aesthetic Use of Neurotoxins: Safety and Informed Consent,” December 28, 2010. “Doses and Units in the Aesthetic use of Neurotoxins,” January 28, 2011. “Patient Satisfaction During Aesthetic Neurotoxin Treatment,” February 22, 2011.
  34. Faculty, Annual Meeting of the American Academy of Dermatology, “Managing Filler Complications,” New Orleans, LA, Feb. 2011
  35. Poster, “A case report of lignin peroxidase lotion used to treat post-inflammatory hyperpigmentation in skin type V,” presented at the Skin of Color Seminar Series, New York City, May 14, 2011.
  36. Faculty, 7th Annual Cosmetic Surgery Vegas, Presentations: “Coordination of the Aesthetic Team,” June 25, 2011 and Masters Session “Step by Step Nonsurgical Facial Rejuvenation,” June 26, 2011
  37. Invited speaker, 2011 ASDS Annual Meeting, “Core Curriculum in Cosmetic Dermatologic Surgery Track: Neurotoxins,” Washington, DC, Nov. 2011
  38. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Dec. 2011
  39. Faculty, Dermaceutic Expert Meeting, Istanbul, Turkey, June, 2012
  40. Faculty, 2012 Vegas Cosmetic Surgery, June 2012
  41. Invited Speaker, 2012 ASDS Annual Meeting. “Core Curriculum in Cosmetic Dermatologic Surgery track: Neurotoxins,” Atlanta, GA, October 2012
  42. Invited Guest Speaker, “Treatment Strategies for Melasma and Hyperpigmentation,” Elure (Syneron Topical Aesthetics), Israeli Launch, Tel Aviv, Jerusalem, and Haifa, Israel, October, 2012
  43. Invited Speaker, Ultimate Skin Health Symposium, “Combination Treatments for Facial Rejuvenation,” Los Angeles, CA, Nov. 9-11, 2012
  44. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Nov.29-Dec. 2, 2012
PUBLICATIONS
  1. Wasserteil, V. Bruce, 5: Fever and hypotrichosis in a newborn. Arch Dermatol. 1986. 122:1325-1330.
  2. Wasserteil, V. Bruce, 5: Ricardi, VM: Non-von Recklinghausen’s neurofibromatosis presenting as hemifacial neurofibromas and contralateral cafd-au-lait- spots. J Am Acad Dermatol, 1987. 16:1090-1096.
  3. Wasserteil, V. Jimenez-Acosta, FJ. Kerdel, FA: Disseminated histoplasmosis presenting as a rosacea-like eruption in a patient with the acquired immunodeficiency syndrome. Inter. J. Dermatol. 1990.29:649-651.
  4. Wasserteil, V. Kerdel, FA: A case of Erythema Dyschromicum Perstans. Self-Assessment. Examination for the American Academy of Dermatology. JAm Acad Dermatol. 1989. 21:604-608
  5. Mertz, PM. Marshall, DA. Cazzaniga, AL. Wasserteil, V. Eaglstein, WH: The effects of a new antimicrobial peptide magainin on pseudomonas aeruginosa proliferation in wounds (Abstract). J Invest Dermatol. 1990. 94:555.
  6. Wasserteil, V. Bruce, S: Fievre et hypotrichose chez un noouveau-ne. Les cases cliniques des archives of dermatology. 1990. 2:19-21.
  7. Wasserteil, V. Bruce, 5, Sessoms SL, et al. Pyoderma gangrenosum treated with hyperbaric oxygen therapy. Int J Dermatol 1992. 31:594-6.
  8. Bucay, VW: Ironic Diagnosis ‘Changes Life Forever’. San Antonio Medicine. 2006. 59(10):32-33
  9. Bucay, VW: A Dermatologist’s Battle with Melanoma. The Skin Cancer Foundation Journal. 2008. XXVI:52-56
  10. Bucay, VW: Surviving Advanced Melanoma: A Dermatologist’s Personal Perspective. The Melanoma Letter, Vol. 26, No. 3, 2008
  11. Bucay, V: Building the Skin Care Regimen: Choosing the right ingredients. Practical Dermatology. Feb. 2011, p. 31-38.
  12. Maas C, Kane MAC, Bucay VW, et al. Current Aesthetic Use of AbobotulinumtoxinA in Clinical Practice: An Evidence-Based Consensus Review. Aesthet Surg J 2012; 32:8S-29S.
  13. Bucay VW, Day D. Adjunctive Skin Care of the Periorbital Region and Brow. Clin Plastic Surg, 2013; 40: 225-236.
  14. Vega JM, Bucay VW, Mayoral FA. Prospective, Multicenter Study to Determine the Safety and Efficacy of a Unique Radiofrequency Device for Moderate to Severe Hand Wrinkles. J Drugs Dermatol. 2013; 12(1): 24-26.
PRESENTATIONS (during post-graduate training)
  1. Wasserteil, V. Jimenez- Acosta, FJ. Kerdel, FA: Disseminated Histoplasmosis Resembling Rosacea in a Patient with AIDS. Gross and Microscopic Symposium. 48” Annual Meeting of the American Academy of Dermatology. December 2, 1989.
  2. Wasserteil, V. Bruce, S. Fehir, K. Sessoms, 5: Dermatomyositis- like Eruption Associated with Chemotherapy for Non-Hodgkin’s Lymphoma. 22 Annual Meeting of the South Central Dermatology Congress. January 28, 1990.
  3. Wasserteil, V. Levy, ML: Benign Cephalic Histiocytosis. Gross and Microscopic Symposium. 49th Annual Meeting of the American Academy of Dermatology. December 1, 1990.
  4. Mertz, PM. Marshall, DA. Cazzaniga, AL. Wasserteil, V. Berkowitz, B: Effect of a topical magainin on Pseudomonas aeruginosa proliferation in wounds. (Poster) American Society of investigative Dermatology. May 2-5, 1990.
  5. Mertz, PM. Marshall, DA. Cazzaniga, AL. Wasserteil, V. Eaglstein, WH. Berkowitz, B: Effect of a topical magainin on Pseudomonas aeruginosa proliferation in wounds. (Poster) American Society of Microbiology. May 1990.
  6. Mertz, PM. Marshall, DA. Cazzaniga, AL Wasserteil, V. Eaglstein, WH. Berkowitz, B: Effect of a topical magainin on Pseudomonas aeruginosa proliferation in wounds. (Poster) 49th Annual Academy of Dermatology. December 1-6, 1990.
RESEARCH /STUDIES
  1. Enzyme Kinetics and the Relationship of Beta-Glucuronnidase Release to Platelet Viability in Stored and Frozen Platelet Concentrates (under J.P. Hester, M.D.). Summer Program in Biomedical sciences at M.D. Anderson Hospital and Tumor Institute, Houston, Texas. 1979.
  2. The effects of Anticoagulants on in vitro Lymphocyte Transformation (under J.P. Hester, M.D.). M.D. Anderson Hospital and Tumor Institute, Houston, Texas. 1980-1981.
  3. Research Assistant at the Johns Hopkins Oncology Center, Baltimore, M.D. (under R, Tucker, M.D., Ph D.) 1982-1983.
  4. Androgen Receptors in Becker’s Nevus (under S. Bruce, M.D.). Baylor College of Medicine, Houston, Texas. 1986.
  5. Topical Magainins in the Treatment of Infected Skin Wounds (under William H. Eaglstein, M.D.) University of Miami School of Medicine, Department of Dermatology, Miami, Florida 1988-1989.
  6. An open-label. Non-Controlled Study of Calcipotriol (MC903/bmy 30434) Ointment (0.005%) in the Long-Term Treatment of Plaque Psoriasis. Baylor College of Medicine. Houston, Texas.
  7. Controlled Trial Comparing Sulconazole Nitrate/Hydrocortisone Valerate Gel, Sulconazole Nitrate Gel and Hydrocortisone Valerate Gel in the Treatment of Tinea Pedis. Baylor College of Medicine. Houston, Texas.
  8. Double Blind, Bilateral, Paired Comparison Study of Ultravate Ointment 0.05% in the Treatment of Plaque Psoriasis. Baylor College of Medicine. Houston, Texas.
  9. Prospective, Multicenter Study to determine the Safety and Efficacy of a Unique Rediofrequency Device on Moderate to Severe Hand Wrinkles. Miami, Florida and San Antonio, Texas, 2011.
LASER EXPERIENCE
    • Candela, Pulsed dye laser
      Baylor College of Medicine
      Houston, Texas
      1990-1991
    • Carbon Dioxide Laser
      Baylor College of Medicine
      Houston, Texas
      1989-1991
    • Workshop in the use of Ultrapulse C02 Laser for Aesthetic Procedures
      Richard 0. Gregory, M.D.
      Orlando, Florida
      1995
    • Preceptorship in the use of the Ultrapulse CO2 laser for Aesthetic Procedures
      Richard F. Fitzpatrick, M.D.
      La Jolla, California
      1996
    • Workshop and Preceptor ship in the use of the Ultrapulse C02 laser for Aesthetic procedures.
      Larry Shoenrock, M.D.
      Santa Rosa, California
      1996
    • Coordinator of workshop in the use of the Ultrapulse C02 laser for aesthetic procedures.
      Mexico City, Mexico
      1996
    • Coordinator of workshop in the use of the Ultrapulse C02 laser for aesthetic procedures.
      Pan American Congress of Ophthalmology
      Cancun, Mexico
      1997
  • Workshop in the use of the Epilaser for Hair Removal
    Rube J. Pardo M.D., Ph D.
    Miami, Florida
    1997
CONSULTANT/ADVISORY BOARD/SPEAKER
  • Allergan, Inc.
  • Medicis Aesthetics, Inc
  • Procter and Gamble
  • AVEENO division of Johnson and Johnson
  • Ortho Neutrogena Division of Johnson and Johnson
  • Novartis Pharmaceuticals
  • Bioform/Merz
  • Biopelle/Ferndale
  • Galderma
  • Laboratorios ISDIN (Spain)
  • April Rain Skin Science (Guiding dermatologist)
  • Syneron Topical Aesthetics
  • Ellman International, Inc.
  • Precision Dermatology, Inc.
  • NeoStrata
CREDENTIALING

Allergan

Brilliant Distinctions Rewards Program

  • Black Diamond provider with Allergan (maker of BOTOX, Juvederm, VOLUMA and SkinMedica) which is in top 2% in nation
  • Dr. Vivian Bucay Juvederm Voluma Master Trainer as well as BTX trainer for Allergan
  • One of the first in Texas to perfrom Kybella. Trained all physicians in South Texas on the procedure

Galderma (maker of Restylane Silk, Restylane Lyft, Dysport, Suclptra Aesthetic)

Aspire Rewards Program

  • Dr. Bucay is The EXCLUSIVE Trainer for Galderma Aesthetic & Corrective for ALL of South Texas! So there’s arguably no one more sought-after for Dysport, Restylane, Sculptra, and the ALL-NEW Restylane Silk than Dr. Vivian Bucay!
  • This means you can trust Dr. Vivian Bucay with all of your skin care needs, to make sure you look and feel your very best!

MERZ Aesthetics

  • Dr. Bucay is an Ambassador Provider with MERZ Aesthetics makers of Radiesse, Belotero and Xeomin- Ambassador is recognized as the highest level in the nation
  • Dr. Bucay is a Key Opinion Leader with MERZ Aesthetics
  • Bucay Center for Dermatology  and Aesthetics is recognized as a “Center of Excellence” in the United States for Radiesse Hands
  • Dr.Bucay is also a National and International Speaker for Ultherapy, a MERZ family member
  • Dr. Bucay is the FIRST to offer Cellfina in San Antonio and one of the first in the country
MEDIA EXPERIENCE
  • Television “Un Nuevo Dia” — Discussed Facial Rejuvenation using laser resurfacing. June 1998, Mexico City, Mexico.
  • WOAI NBC Affiliate Television Station, San Antonio, TX- Dermatology expert with regular television appearances on the LIVING SHOW to discuss various topics about medical and cosmetic dermatology, 2002-2008
  • KENS CBS Affiliate television station, San Antonio, TX News segments on various topics in medical and cosmetic dermatology
  • Univision 41, Univision Affiliate San Antonio, TX- Featured dermatologist since 2001 on the talk show DESDE SAN ANTONIO regarding skin problems in Hispanics
  • Print media: quoted in San Antonio Express News, Cosmetic Surgery Times, Dermatology Times, Skin and Allergy News, Plastic Surgery Practice, New Beauty, Allure, Shape, More, Good Housekeeping, Fitness, and Elle

Dr. Vivian Bucay is a Top 10 Dermatologist in Middle America in 2016!

dr-bucay-aesthetic-everything